Long-Term Improvement in Patients with moderate to severe atopic Dermatitis treated with Tralokinumab: An ECZTEND Interim Analysis

被引：0
|
作者：
Beissert, Stefan [1 ]
Blauvelt, Andrew [2 ]
Lacour, Jean-Philippe [3 ]
Toth, Darryl [4 ]
Laquer, Vivian [5 ]
Herranz, Pedro [6 ]
Pink, Andrew [7 ]
Peris, Ketty [8 ]
Fangel, Stine [9 ]
Saeki, Hidehisa [10 ]
Wollenberg, Andreas [11 ]
机构：
[1] Univ Klinikum Carl Gustav Carus, Klin & Poliklin Dermatol, Dresden, Germany
[2] Oregon Med Res Ctr, Portland, OR USA
[3] Univ Hosp Nice Cote Azur, Dept Dermatol, Nice, France
[4] Prob Med Res, Windsor, ON, Canada
[5] First OC Dermatol, Fountain Valley, CA USA
[6] La Paz Univ Hosp, Madrid, Spain
[7] Guys & St Thomas Hosp, St Johns Inst Dermatol, London, England
[8] Univ Cattolica Sacro Cuore, Inst Dermatol, Rom, Italy
[9] LEO Pharma AS, Ballerup, Denmark
[10] Nippon Med Sch, Dept Dermatol, Tokyo, Japan
[11] Ludwig Maximilians Univ Munchen, Klinikum LMU Munchen, Klin & Poliklin Dermatol & Allergol, Munich, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2022年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P049
引用
收藏
页码：29 / 30
页数：2
相关论文
共 50 条
  • [21] Continuous tralokinumab treatment over 4 years in adults with moderate-to-severe atopic dermatitis provides long-term disease control
    Blauvelt, Andrew
    Langley, Richard G.
    Peris, Ketty
    Silvestre, Juan Francisco
    Katoh, Norito
    Tauber, Marie
    Pinter, Andreas
    Ameen, Mahreen
    Gooderham, Melinda
    Oland, Christian Bjerregard
    Tindberg, Ann-Marie
    Gjerum, Le
    Reich, Kristian
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II48 - II49
  • [22] Efficacy and safety of long-term treatment with dupilumab for moderate to severe atopic dermatitis
    Ikeda, M.
    Uehara, H.
    Tsuge, M.
    ALLERGY, 2019, 74 : 182 - 182
  • [23] Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis
    Edwards, Steven J.
    Karner, Charlotta
    Jhita, Tracey
    Barton, Samantha
    Marceniuk, Gemma
    Yiu, Zenas Z. N.
    Wittmann, Miriam
    HEALTH TECHNOLOGY ASSESSMENT, 2024, 28 (04)
  • [24] Population Pharmacokinetics of Tralokinumab in Adult Subjects With Moderate to Severe Atopic Dermatitis
    Soehoel, Anders
    Larsen, Malte Selch
    Timmermann, Stine
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (08): : 910 - 921
  • [25] LONG-TERM SAFETY IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS TREATED WITH DUPILUMAB UP TO 4 YEARS
    Blauvelt, A.
    Eichenfield, L.
    Sierka, D.
    Chen, Z.
    Khokhar, F.
    Marco, A. Rodriguez
    Shabbir, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S19 - S19
  • [26] Long-term treatment with tralokinumab normalizes the molecular gene signature of atopic dermatitis
    Guttman-Yassky, E.
    Pavel, A.
    Kabashima, K.
    Staumont-Salle, D.
    Eyerich, K.
    Nahm, W.
    Pauser, S.
    Da Rosa, J. C.
    Roepke, M.
    Amoudruz, P.
    Blauvelt, A.
    Reich, K.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 27 - 28
  • [27] Long-term treatment with tralokinumab normalizes the molecular gene signature of atopic dermatitis
    Guttman-Yassky, E.
    Pavel, A.
    Kabashima, K.
    Staumont-Salle, D.
    Eyerich, K.
    Nahm, W.
    Pauser, S.
    Da Rosa, J. Correa
    Roepke, M.
    Amoudruz, P.
    Schneider, S.
    Blauvelt, A.
    Reich, K.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E146 - E147
  • [28] Long-term treatment with tralokinumab normalizes the molecular gene signature of atopic dermatitis
    Guttman-Yassky, E.
    Pavel, A.
    Kabashima, K.
    Staumont-Salle, D.
    Eyerich, K.
    Nahm, W.
    Pauser, S.
    Da Rosa, J. Correa
    Ropke, M.
    Amoudruz, P.
    Blauvelt, A.
    Reich, K.
    ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 567 - 567
  • [29] Predicting success with reduced dosing frequency of tralokinumab in patients with moderate-to-severe atopic dermatitis
    Weidinger, Stephan
    Bewley, Anthony
    Hong, H. Chih-ho
    Silvestre, Juan Francisco
    Peris, Ketty
    Wollenberg, Andreas
    Ivens, Ulla
    Soehoel, Anders
    Steffensen, Louise Abildgaard
    Tindberg, Ann-Marie
    Simpson, Eric L.
    BRITISH JOURNAL OF DERMATOLOGY, 2025, 192 (03) : 410 - 419
  • [30] Dupilumab treatment provides long-term improvement in itch in pediatric patients with moderate-to-severe atopic dermatitis over 1 year
    Siegfried, Elaine
    Simpson, Eric L.
    Boguniewicz, Mark
    Flohr, Carsten
    Eichenfield, Lawrence F.
    Pinter, Andreas
    Ramien, Michele
    Gao, Xing-Hua
    Chen, Zhen
    Bates, Lauren
    Rossi, Ana B.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II56 - II57
12345